• OUT-LICENSING
• IN-LICENSING
• CORPORATE ALLIANCES
• MERGERS & ACQUISITIONS

ProPharma has extensive experience working closely on a local regional or global basis with biotechnology and pharmaceutical companies. Strategic plan development and implementation are activities ProPharma routinely undertakes for client companies.

With offices in the San Francisco Bay Area, London and Tokyo, ProPharma can seamlessly provide a global reach to meet business development objectives. ProPharma is equally effective in assisting companies access in-licensing candidates and technologies and in helping companies out-license products or technologies in situations where the licensing company does not have the resources and/or infrastructure to proceed independently. ProPharma will define and negotiate terms when requested by clients.

• PRECLINICAL STUDIES DESIGN AND MANAGEMENT
• GLOBAL CLINICAL TRIAL PLANNING AND MANAGEMENT
• SUPPORT FOR PRODUCT LICENSING APPLICATIONS

ProPharma serves client companies in a variety of product development capacities, including development of strategic plans for product development, registration, and marketing; design and management of pre-clinical and clinical studies; preparation of regulatory applications and reports; assisting clients in meetings with regulatory agencies; representing clients in meetings with potential corporate partners and investors, and evaluating development aspects of business plans and product licensing opportunities. With experts in Europe and the United States, ProPharma is positioned to provide unique drug development assistance. The pre-clinical plan is always developed with the requirements of the desired therapeutic indications in mind. ProPharma is able to apply its considerable experience in clinical development to assist companies in defining clinical plans that will be acceptable to FDA and will support an effective marketing campaign. In particular, ProPharma has extensive experience in assisting companies define the most efficient and cost effective set of studies that will be necessary for a regulatory filing.

• IP ASSESSMENT AND MANAGEMENT

Intellectual property is the basis of value for all life sciences companies. ProPharma has specialized expertise in evaluation and development of world-class IP portfolios. Dr. Peter Cozens' broad experience in both defending and enforcing patents throughout Europe, the USA and Japan places ProPharma in a unique position to evaluate the patent portfolios of clients and their competitors. Patent auditing and/or management by ProPharma will ensure efficient use of intellectual property assets by clients. ProPharma will also review freedom-to-operate issues with business advice on avoiding patent litigation or strengthening the clients position with respect to it. The Partners can also help where necessary in obtaining required licenses.

• BUSINESS PLANS
• FINANCING
• VALUATIONS

ProPharma possesses extensive experience in working with start-up companies with limited infrastructure and pharmaceutical experience to develop a cohesive and focused business plan that can serve as a blue print for both operations and fund raising. ProPharma is also effective in applying its operational experience in drug development, finance and administration to assist in the implementation of a clearly defined plan.

Breadth of industry experience, and financial expertise enables ProPharma to provide R&D and intellectual property asset valuations. experience working with financial advisory firms, investment banks and venture capital partnerships.